BSF ENTERPRISE PLC Logo

BSF ENTERPRISE PLC

Biotech investor developing cell-based tissue solutions for food, materials, and health markets.

BSFA | IL

Overview

Corporate Details

ISIN(s):
GB00BHNBDQ51
LEI:
2138007PJT69H8FYLC06
Country:
United Kingdom
Address:
C/O LOCKE LORD (UK) LLP, EC2M 3AB LONDON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

BSF Enterprise PLC is a biotechnology investment company that develops and commercializes a portfolio of cell-based tissue engineering solutions. The company focuses on addressing global challenges in health, food sustainability, and environmental protection by providing investors with access to next-generation, ethical innovations. Its core portfolio includes companies pioneering the development of 100% naturally structured lab-grown leather and cultivated meat, human corneal tissues for medical repair, and advanced cell-culture media for the tissue engineering sector. BSF Enterprise also operates to bridge its technological innovations with key international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-01 08:50
Share Issue/Capital Change
Proposed Equity Fundraise - Strategic Direction
English 16.0 KB
2025-12-01 08:20
Pre-Annual General Meeting Information
Equity Fundraise & Notice of General Meeting
English 41.5 KB
2025-11-29 08:14
Pre-Annual General Meeting Information
Notice of General Meeting
English 117.1 KB
2025-07-10 08:00
M&A Activity
Agreement
English 13.4 KB
2025-06-25 08:00
Earnings Release
Interim 2025 Results
English 297.7 KB
2025-05-23 08:00
Share Issue/Capital Change
15p Warrants Amended
English 9.3 KB
2025-03-13 08:00
Environmental & Social Information
3DBT Lab Grown Leather Commercialization
English 10.7 KB
2025-03-06 16:51
Prospectus
Publication of a Prospectus
English 15.4 KB
2025-03-06 16:33
Prospectus
Publication of Prospectus
English 98.7 KB
2025-03-06 16:29
Prospectus
Prospectus
English 1017.5 KB
2025-03-05 13:10
AGM Information
Result of Annual General Meeting
English 27.3 KB
2025-02-11 09:21
Delisting Announcement
Expected admission of shares - Replacement
English 8.6 KB
2025-02-11 08:00
Share Issue/Capital Change
AIM Admission - Update
English 8.3 KB
2025-02-10 08:00
Pre-Annual General Meeting Information
AGM Statement
English 9.7 KB
2025-02-07 18:23
Proxy Solicitation & Information Statement
Proxy Form
English 125.0 KB

Automate Your Workflow. Get a real-time feed of all BSF ENTERPRISE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BSF ENTERPRISE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BSF ENTERPRISE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland
ACHI
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
Aladdin Healthcare Technologies SE Logo
Develops AI for drug discovery and diagnostics targeting age-related diseases.
Germany
NMI
AlzeCure Pharma Logo
Develops small-molecule drug therapies for Alzheimer's, pain, and cognitive dysfunction.
Sweden
ALZCUR
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden
APTA
APTAMER GROUP PLC Logo
Develops custom aptamer-based binders as antibody alternatives for life science applications.
United Kingdom
APTA
Aran Research & Development (1982) Ltd. Logo
End-to-end product & machine development for plastics, medical, and industrial markets.
Israel
ARAN

Talk to a Data Expert

Have a question? We'll get back to you promptly.